| News |
![]()
|
CARDIFF AND SEWARD C... | | | AUTONOMY DELIGHTED T... | | | NEW YORK LIFE UPGRAD... |
![]()
|
![]() |
![]() |
![]() |
Autonomy Delighted To Announce Launch Of Isabel
Online clinical decision support and information system is launched to help prevent misdiagnosis in children
CAMBRIDGE, UK-June 17, 2002- Autonomy Corporation plc (Nasdaq: AUTN; LSE: AU.; Nasdaq Europe: AUTN), today announced the launch of the ISABEL clinical decision support system for medical professionals, which is based on Autonomy's sophisticated infrastructure software. ISABEL aims to bridge the knowledge gap that exists in many health systems, notably that most of the critical knowledge and experience resides with senior consultants in hospitals and not with the doctors who first examine patients.
ISABEL is a free of charge online clinical decision support system that is available to all registered health professionals, providing critical support in areas such as diagnosis, treatment guidelines and shared experience. ISABEL, which currently concentrates on pediatrics, also offers an annotated image library, allowing users to compare their patients' visible symptoms with those available on the site, and consequently assist them in making a potentially life-saving diagnosis.
Autonomy donated its pattern-matching software to the Isabel Medical Charity to enable fast, accurate assistance for all medical professionals, who often do not have the benefit of the more specialist knowledge required to make accurate diagnoses. Applying Autonomy's pattern matching software to medical textbooks enables ISABEL to deliver a fast and practical differential diagnostic tool. When using ISABEL the doctor simply needs to type in a patient's symptoms from which the Autonomy software will extract the key ideas before searching ISABEL's extensive library of content to find a similar combination of symptoms - and consequently suggesting a range of relevant diagnoses. In essence, this mimics the doctor's existing and intuitive diagnostic process, the difference being that the system's base of textbook knowledge is far larger than can readily be stored in the human brain. Its performance is also unaffected by tiredness and overwork.
The charity's goals are primarily to reduce the number of children becoming seriously ill as a result of incorrect or delayed diagnosis, and to increase survival chances of sick children by ensuring that suitable treatment is administered immediately as a result of ready availability of expert guidelines compiled by acknowledged experts in specific fields of medicine. Even before its public launch, ISABEL has attracted over 3,000 users and already has extensive support from within the medical profession and the Department of Health.
Mike Lynch, Founder and CEO of Autonomy Corporation today commented, "Autonomy is delighted to be supporting the Isabel Medical Charity. ISABEL will offer a critical resource to help doctors reduce the risk of error in the diagnosis of children's illnesses, and encourage dissemination of knowledge within the medical profession".
Jason and Charlotte Maude, founders of The Isabel Medical Charity today commented, "ISABEL has only been made possible by the use of Autonomy's software and as a small charity, we could not have developed the system in such a short space of time without the generous donation from Autonomy for which we are very grateful."
Autonomy's unique Intelligent Data Operating Layer (IDOL) integrates unstructured, semi-structured and structured information from multiple repositories through an understanding of the content. At the heart of Autonomy's software is its ability to analyze text and voice (in any language) and identify and rank the main concepts within it. It then automatically categorizes, links, personalizes and delivers that information. Autonomy's infrastructure technology is used to automate operations within enterprise information portals, customer relationship management, knowledge management, business intelligence and e-business applications, among others.
About Autonomy
Autonomy Corporation plc (Nasdaq: AUTN; Nasdaq Europe: AUTN; LSE: AU.) is a global leader in infrastructure software for the enterprise. Autonomy's technology powers applications dependent upon unstructured information including e-commerce, customer relationship management, knowledge management, enterprise information portals, enterprise resource planning and online publishing. Autonomy's customer base includes more than 550 global companies, including Hutchison 3G, Channel 4, Deutsche Bank, AT&T, AstraZeneca, BAE Systems, Ford, Ericsson, General Motors, Lucent, Royal Sun Alliance, Sun Microsystems and public sector agencies including the UK Government's Department of Trade and Industry, NASA, the US Department of Defense and the US Department of Energy. Strategic reseller and OEM partners include leading companies such as BEA, Business Objects, Computer Associates, Hewlett Packard, IBM Global Services, Oracle, Vignette and Sybase. The company has offices in North America, Europe, Asia and Australia and is on the Web at http://www.autonomy.com/
About ISABEL
Jason and Charlotte Maude founded the project in July 1999 together with Dr Joseph Britto, Paediatric Intensive Care Consultant at St Mary's Hospital, Paddington, London. Three months prior to this, the Maudes' 3-year-old daughter, Isabel, had spent a month in Intensive Care suffering multiple organ failure and cardiac arrest and a further month in a High Dependency ward. All this because her local A&E department and GP had failed to recognise her critical, life-threatening symptoms following chicken pox. Against all odds, Isabel's sole legacy is a large wound requiring extensive plastic surgery. During their time in hospital, the idea of a diagnostic tool slowly evolved during conversations between the Maudes and Dr Britto, who gradually gathered the support of a number of high profile doctors from hospitals around the country to make up the ISABEL team. The Isabel Medical Charity received charitable status in April 2000. Its registered office is in London. Further information is on the web at http://www.isabel.org.uk/
Caution Concerning Forward-Looking Statements
With the exception of historical information, the matters set forth in this news release are forward-looking statements that involve risks and uncertainties. A number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, among others, technology risks, including dependence on core technology; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; growth of the Internet; financial risk management; and future growth subject to risks. These factors and other factors which could cause actual results to differ materially are also discussed in the company's filings with the United States Securities and Exchange Commission, including Autonomy's Annual Report on Form 20-F and Registration Statements on Form F-1.
| For more information, please contact: | |
|
Ian Black Autonomy Corporation plc +44 (0) 1223 448 000 ianb@autonomy.com |
Jason/Charlotte Maude ISABEL Medical Charity +44 (0) 208 748 4330 info@isabel.org.uk |
Forthcoming Events
| Protect Webinar |
Archived Events
| Power Webinar |
This is a selection of our forthcoming events, please visit our seminars page for more information.
Automatic Hyperlinks provided by IDOL Server
|
|
|
|
|
|
|
|
|
|
|
|
This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.
Automatic Hyperlinks provided by IDOL Server
























































Find us on Facebook
Follow us on Twitter
See us on YouTube
Find us on LinkedIn







